CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%
CBD Life Sciences Inc. (CBDL) has reported a remarkable 500% increase in online sales for Q1 2025, marking significant growth in the wellness sector. The company has expanded beyond traditional CBD products, introducing wellness formulations that include Reishi, Lion's Mane, and Ashwagandha adaptogens.
Key developments include:
- Launch of CBD Kava & Kratom Shots as natural alternatives to caffeine
- Expansion to Walmart Marketplace and DoorDash platforms
- Implementation of proprietary Nano-CBD Technology
- Focus on US-made, third-party tested products with clean-label ingredients
The company is positioning itself at the intersection of the CBD market (projected to exceed $60 billion by 2030) and the functional mushroom market (expected to reach $24 billion by 2032). Their top-selling products include 3000MG Pain Relief Cream, CBD Kava & Kratom Shots, and Mushroom Wellness Blends.
CBD Life Sciences Inc. (CBDL) ha riportato un notevole aumento del 500% delle vendite online per il primo trimestre del 2025, segnando una crescita significativa nel settore del benessere. L'azienda si è espansa oltre i tradizionali prodotti a base di CBD, introducendo formulazioni per il benessere che includono adattogeni come Reishi, Lion's Mane e Ashwagandha.
Sviluppi chiave includono:
- Lancio di CBD Kava & Kratom Shots come alternative naturali alla caffeina
- Espansione sulle piattaforme Walmart Marketplace e DoorDash
- Implementazione della tecnologia proprietaria Nano-CBD
- Focus su prodotti realizzati negli Stati Uniti, testati da terzi e con ingredienti a etichetta pulita
L'azienda si sta posizionando all'incrocio tra il mercato del CBD (che si prevede supererà i 60 miliardi di dollari entro il 2030) e il mercato dei funghi funzionali (che si prevede raggiungerà i 24 miliardi di dollari entro il 2032). I loro prodotti più venduti includono la crema per il dolore da 3000MG, CBD Kava & Kratom Shots e Mischie di Benessere a base di Funghi.
CBD Life Sciences Inc. (CBDL) ha reportado un notable aumento del 500% en las ventas en línea para el primer trimestre de 2025, marcando un crecimiento significativo en el sector del bienestar. La empresa se ha expandido más allá de los productos tradicionales de CBD, introduciendo formulaciones de bienestar que incluyen adaptógenos como Reishi, Lion's Mane y Ashwagandha.
Los desarrollos clave incluyen:
- Lanzamiento de CBD Kava & Kratom Shots como alternativas naturales a la cafeína
- Expansión a las plataformas Walmart Marketplace y DoorDash
- Implementación de la tecnología propietaria Nano-CBD
- Enfoque en productos fabricados en EE. UU., probados por terceros y con ingredientes de etiqueta limpia
La empresa se está posicionando en la intersección del mercado de CBD (se proyecta que superará los 60 mil millones de dólares para 2030) y el mercado de hongos funcionales (se espera que alcance los 24 mil millones de dólares para 2032). Sus productos más vendidos incluyen crema para el dolor de 3000MG, CBD Kava & Kratom Shots y mezclas de bienestar de hongos.
CBD Life Sciences Inc. (CBDL)는 2025년 1분기 온라인 판매가 500% 증가했다고 보고하며 웰니스 분야에서의 중요한 성장을 나타냈습니다. 이 회사는 전통적인 CBD 제품을 넘어 Reishi, Lion's Mane 및 Ashwagandha와 같은 적응성 성분을 포함한 웰니스 포뮬레이션을 도입했습니다.
주요 개발 사항은 다음과 같습니다:
- 카페인의 자연 대안으로서 CBD Kava & Kratom Shots 출시
- Walmart Marketplace 및 DoorDash 플랫폼으로의 확장
- 독자적인 Nano-CBD 기술 구현
- 미국산, 제3자 테스트 제품과 클린 라벨 성분에 중점
회사는 CBD 시장(2030년까지 600억 달러를 초과할 것으로 예상)과 기능성 버섯 시장(2032년까지 240억 달러에 도달할 것으로 예상)의 교차점에서 자신을 포지셔닝하고 있습니다. 그들의 베스트셀러 제품에는 3000MG 통증 완화 크림, CBD Kava & Kratom Shots 및 버섯 웰니스 블렌드가 포함됩니다.
CBD Life Sciences Inc. (CBDL) a signalé une augmentation remarquable de 500 % des ventes en ligne pour le premier trimestre 2025, marquant une croissance significative dans le secteur du bien-être. L'entreprise s'est étendue au-delà des produits CBD traditionnels, introduisant des formulations de bien-être qui incluent des adaptogènes tels que le Reishi, la Lion's Mane et l'Ashwagandha.
Les développements clés incluent:
- Lancement de CBD Kava & Kratom Shots comme alternatives naturelles à la caféine
- Expansion sur les plateformes Walmart Marketplace et DoorDash
- Mise en œuvre de la technologie propriétaire Nano-CBD
- Accent sur les produits fabriqués aux États-Unis, testés par des tiers et avec des ingrédients à étiquette propre
L'entreprise se positionne à l'intersection du marché du CBD (prévu pour dépasser 60 milliards de dollars d'ici 2030) et du marché des champignons fonctionnels (prévu pour atteindre 24 milliards de dollars d'ici 2032). Leurs produits les plus vendus incluent la crème anti-douleur de 3000MG, CBD Kava & Kratom Shots et des mélanges de bien-être à base de champignons.
CBD Life Sciences Inc. (CBDL) hat einen bemerkenswerten 500% Anstieg der Online-Verkäufe für das erste Quartal 2025 gemeldet, was ein signifikantes Wachstum im Wellness-Sektor markiert. Das Unternehmen hat sich über traditionelle CBD-Produkte hinaus erweitert und Wellness-Formulierungen eingeführt, die Adaptogene wie Reishi, Lion's Mane und Ashwagandha enthalten.
Wichtige Entwicklungen umfassen:
- Einführung von CBD Kava & Kratom Shots als natürliche Alternativen zu Koffein
- Expansion auf die Plattformen Walmart Marketplace und DoorDash
- Implementierung der proprietären Nano-CBD-Technologie
- Fokus auf in den USA hergestellte, von Dritten getestete Produkte mit sauberen Inhaltsstoffen
Das Unternehmen positioniert sich an der Schnittstelle zwischen dem CBD-Markt (der voraussichtlich bis 2030 über 60 Milliarden Dollar übersteigen wird) und dem Markt für funktionale Pilze (der voraussichtlich bis 2032 24 Milliarden Dollar erreichen wird). Zu den meistverkauften Produkten gehören die 3000MG Schmerzcreme, CBD Kava & Kratom Shots und Pilz-Wellness-Mischungen.
- 500% increase in online sales for Q1 2025
- Expansion to major retail platforms: Walmart Marketplace and DoorDash
- Development of proprietary Nano-CBD Technology
- Diversification into high-growth functional mushroom market
- None.
With the global wellness industry exploding past
SCOTTSDALE, AZ / ACCESS Newswire / April 10, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is thrilled to announce a
This milestone reflects the company's relentless focus on innovation, clean ingredients, and product efficacy. From cutting-edge CBD topicals to adaptogenic mushroom blends, CBDL is gaining significant traction in both consumer markets and investor circles.
"We're not just selling CBD anymore," said CEO Lisa Nelson. "We're creating a new category of functional wellness - one that blends the healing powers of CBD, mushrooms, and natural ingredients backed by science and built for today's lifestyles."
Positioned in the Heart of a
The wellness industry is booming - valued at
The CBD market, projected to exceed
$60 billion by 2030The functional mushroom market, expected to surpass
$24 billion by 2032
CBD Life Sciences Inc. is going beyond traditional CBD by launching wellness-forward formulations that include Reishi, Lion's Mane, and Ashwagandha - powerful adaptogens known for reducing stress, improving focus, boosting immunity, and fighting inflammation. The company's line of CBD Kava & Kratom Shots is also gaining momentum as a natural alternative to caffeine, energy drinks, and synthetic stress relief.
CBDL's Momentum is Just Getting Started:
500% + online sales growth in Q1 2025Top-sellers: 3000MG Pain Relief Cream, CBD Kava & Kratom Shots, Mushroom Wellness Blends
Retail Expansion:
Now selling on Walmart Marketplace
Products available through DoorDash in select markets
More e-commerce and delivery partnerships in development
Innovative Product Development:
Proprietary Nano-CBD Technology for maximum bioavailability
Launch of adaptogenic mushroom products including Reishi, Lion's Mane, and Ashwagandha
Domestic Production & Compliance:
All products made in the USA
Third-party tested for quality and consistency
Clean-label ingredients, no artificial fillers
For Investors
CBD Life Sciences Inc. is not just scaling - it's setting the pace. By strategically expanding into multiple billion-dollar wellness verticals, CBDL is leveraging its momentum to build a brand that is future-proof, health-focused, and ready for mass market adoption.
With more consumers turning to plant-based, functional wellness solutions every day, CBDL stands at the forefront of a generational shift in how people approach health and healing.
For investors seeking to get in on the ground floor of the next wave in natural wellness, CBD Life Sciences Inc. is the name to watch.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) is a leading innovator in the wellness and alternative health sector, specializing in high-quality CBD and functional mushroom products designed to enhance well-being. With a commitment to scientific research and consumer safety, CBDL continues to push the boundaries of holistic health solutions, creating opportunities for exponential growth in a rapidly evolving market.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire